Remove Communication Remove Packaging Remove Presentation
article thumbnail

Insmed wins FDA approval for future blockbuster Brinsupri

Pharmaceutical Technology

In an investor presentation, Insmed stated the drug could generate $5bn in peak sales. The future for Brinsupri is looking bright in its untreaded indication. GlobalData reckons Insemed has a blockbuster on its hands, forecasting sales of $1.7bn by 2033. Around 500,000 people in the US are estimated to have NCFB, according to Insmed.

FDA
article thumbnail

Apertura signs multiple licensing agreements for TfR1 CapX tech

Pharmaceutical Technology

In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Brainerd

Blog: Ask a Student Pharmacist

Students often enjoy engaging in multiple locations due to the appeal of having the same platform while observing how the community needs differ from pharmacy to pharmacy. We specialize in clinical services including medication synchronization, blister packaging, and medication therapy management (MTM).

article thumbnail

Alfasigma sets stage for Jyseleca in axSpA after Phase III win

Pharmaceutical Technology

By GlobalData Learn more about Strategic Intelligence AxSpA is a chronic inflammatory disease that typically presents when patients are in their 30s, impacting the spine and sacroiliac joints and causing significant pain, stiffness and reduced mobility. Don’t let policy changes catch you off guard.

article thumbnail

ViroCell and AvenCell to advance allogeneic CAR-T therapy manufacture

Pharmaceutical Technology

In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.

article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.

article thumbnail

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

Pharmaceutical Technology

In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead. We may still continue to send you service-related and other non-promotional communications.